Madhu Kumar
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Melanoma and MAPK Pathways
- Circular RNAs in diseases
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
Papers in
- Oncology 13
- Cancer Diagnosis and Treatment 6
-
- RNA modifications and cancer 6
- Co-authors
- Tyler Jacks (5 shared papers)Phillip A. Sharp (2 shared papers)Margaret S. Ebert (1 shared paper)Stefan J. Erkeland (1 shared paper)Julian Downward (6 shared papers)Michael D. Feldman (3 shared papers)Marcia S. Brose (3 shared papers)Markus E. Diefenbacher (3 shared papers)
- Journals
- European Journal of Ophthalmology (2 papers)Cancer Cell (2 papers)Cell (2 papers)Blood (1 paper)Genes & Development (1 paper)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Madhu Kumar
39 papers receiving 3.0k citations
Madhu Kumar's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 1.1k
- Molecular Biology 2.2k
- Oncology 740
- Pulmonary and Respiratory Medicine 427
- Pathology and Forensic Medicine 200
Countries citing papers authored by Madhu Kumar
This map shows the geographic impact of Madhu Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu Kumar more than expected).
Fields of papers citing papers by Madhu Kumar
This network shows the impact of papers produced by Madhu Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu Kumar. The network helps show where Madhu Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Madhu Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BRAF and RAS mutations in human lung cancer and melanoma. Hit paper breakdown → | 2002 | 875 |
| 2 | Suppression of non-small cell lung tumor development by the let-7 microRNA family Hit paper breakdown → | 2008 | 740 |
| 3 | 2009 | 358 | |
| 4 | 2013 | 245 | |
| 5 | 2012 | 221 | |
| 6 | 2013 | 143 | |
| 7 | 2013 | 126 | |
| 8 | 2011 | 86 | |
| 9 | 2009 | 72 | |
| 10 | 2006 | 64 | |
| 11 | 2012 | 53 | |
| 12 | 2019 | 27 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 5 | |
| 15 | 2015 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 2012 | 3 |
About Madhu Kumar
Madhu Kumar is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 55 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Cancer and Skin Lesions (5 papers), Cancer-related molecular mechanisms research (5 papers), Metastasis and carcinoma case studies (5 papers), Retinal and Macular Surgery (4 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.2k citations), Oncology (740 citations), Pulmonary and Respiratory Medicine (427 citations) and Pathology and Forensic Medicine (200 citations). Madhu Kumar has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Tyler Jacks, Phillip A. Sharp, Margaret S. Ebert, Stefan J. Erkeland, Julian Downward, Michael D. Feldman, Marcia S. Brose, Markus E. Diefenbacher, Gordon Stamp and Christine Chin. Their work appears in journals such as European Journal of Ophthalmology, Cancer Cell, Cell, Blood and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.